#TeamRocket is heading to #ESCCongress 2024 in London to join the world’s leading cardiology experts to help shape the future of cardiovascular medicine. We’re looking forward to engaging with the European Society of Cardiology and medical experts from around the globe in pursuit of our mission of seeking #GeneTherapy cures for rare and devastating diseases. Learn more: https://lnkd.in/demd_Nw6.
Rocket Pharmaceuticals
Biotechnology
Cranbury, New Jersey 27,832 followers
Developing best-in-class curative gene therapies for rare disorders.
Über uns
Rocket Pharma (NASDAQ: RCKT) is a fully-integrated, clinical-stage company seeking gene therapy cures. Rocket places enormous value on people and takes team member progress and well-being just as seriously as the progress and well-being of its pipeline. We are looking for hands-on team players that enjoy collaborating with colleagues who share a passion for our mission and making a difference for patients. Become an integral part of an agile, highly productive team and help grow an entrepreneurial, scientifically driven organization that is increasingly recognized as a leading biotechnology innovator. In addition to a competitive compensation package featuring a generous 401K match and stock options, positions include excellent health benefits. For more information, please visit www.rocketpharma.com. Twitter: https://bit.ly/2O28aHx YouTube: https://bit.ly/3iNSXIu
- Website
-
http://www.rocketpharma.com
External link for Rocket Pharmaceuticals
- Industrie
- Biotechnology
- Größe des Unternehmens
- 201-500 Mitarbeiter
- Hauptsitz
- Cranbury, New Jersey
- Typ
- Öffentliches Unternehmen
- Gegründet
- 2015
- Spezialitäten
- Biotechnology company, Rare diseases therapeutics development, gene therapy, rare disease, LAD-I, Fanconi Anemia, PKD, Danon Disease, and clinical studies
Standorte
-
Primäre
9 Cedar Brook Dr
Cranbury, New Jersey 08512, US
-
350 5th Avenue
suite 7530
New York, New York 10118, US
Employees at Rocket Pharmaceuticals
Aktualisierungen
-
We’re thrilled to announce the promotion of Peggy M. Speight to Senior Vice President, Head of Quality. Since joining #TeamRocket in 2022, Peggy has played a pivotal role in leading the planning and delivery of our quality assurance strategy throughout the #GeneTherapy development lifecycle. She will lead the Quality Assurance and Quality Control teams as we continue seeking gene therapy cures for patients with rare and devastating diseases. Please join us in congratulating Peggy on her expanded role! #Promotion #BiotechLeaders #RareDisease
-
In honor of #WorldPhotoDay, #TeamRocket proudly recognizes the patients we dedicate ourselves to every day. Patients with rare diseases are our North Star and constant reminder who keep us inspired to seek cures through #GeneTherapy. Learn more about our commitment to patients and families: https://lnkd.in/eSnWPNwN. #Patients #Motivation
-
#DidYouKnow: Rare diseases affect approximately 300 million people worldwide? There are more than 7,000 rare diseases, and while each disease may affect a small number of individuals, collectively they impact a significant portion of the global population. #TeamRocket is seeking #GeneTherapy cures that correct rare and devastating diseases at their root cause, to address high unmet medical needs for patients and their families. Learn more about #TeamRocket’s mission: www.rocketpharma.com.
-
At Rocket Pharmaceuticals, we believe in fostering an environment where all ideas are welcome and the opinion of every team member is valued. We recently asked Charles Shiner, Associate Vice President of Global Marketing, to share what motivates him to support Rocket’s mission of seeking #GeneTherapy cures, and here’s what he said. To learn more about #TeamRocket and our people driven by passion, creativity, and commitment to patients, click here: https://lnkd.in/exrgX9Pj. #CompanyValues #CompanyCulture
-
Today, #TeamRocket is thrilled to recognize #NationalInternDay! We are grateful for our interns' hard work, dedication, and fresh perspectives. Our internship program provides a valuable opportunity for mutual growth. Each day, we are actively seeking to engage their unique viewpoints and provide hands-on experience across various teams at Rocket. As we continue to advance our mission of seeking cures for #GeneTherapy, our internship program reminds us of the importance of collaboration and providing impactful opportunities for #FutureLeaders. Learn more about our team and programs: www.rocketpharma.com. #InternAppreciationDay #ThankYouInterns
-
#TeamRocket would like to extend our heartfelt gratitude to Barry Greenberg, Distinguished Professor of Medicine, Director, Advance Heart Failure Treatment Program UC San Diego, and all the presenters who contributed to the success of the 30th Annual San Diego Heart Failure Symposium! For 30 years, this flagship event organized by Dr. Greenburg has brought together the scientific and medical communities to explore the latest advances in the diagnosis, research, and treatment of heart failure. We are honored to again sponsor this conference and engage with the heart failure community as we seek #GeneTherapy cures for patients with rare cardiovascular diseases. Learn more: www.rocketpharma.com. #SDHF2024
-
#TeamRocket is thrilled to sponsor the 30th Annual San Diego Heart Failure Symposium. Engaging with the medical and scientific communities at this annual event is invaluable in driving forward advances in the recognition and treatment of heart failure. Our team of innovators are hard at work advancing our #AAV #GeneTherapy cardiovascular pipeline of potentially curative treatment options for patients with high unmet needs. Learn more: https://lnkd.in/evPEDXPk. #SDHF2024
-
#TeamRocket had the honor of engaging with the #PKD community at #BridgingLivesPKD, the 2nd Annual International PK Deficiency Conference hosted by Thrive with Pyruvate Kinase Deficiency and the Pyruvate Kinase Deficiency Foundation. Patients are our North Star, and having meaningful interactions with patients and advocates fuels our team’s pursuit of #GeneTherapy cures. Thanks to everyone who made this event a success and for your unwavering support for the PKD patient and advocacy community. #PKDConference #PKDeficiency
-
#TeamRocket recently came together to honor our commitment to the community during our annual Rocket Day of Service, celebrated on the day of Rocket’s founding. From Cranbury, NJ, to NYC and beyond, our employees volunteered their time and energy to make a positive impact on those in need. Our mission extends beyond #GeneTherapy; it’s about serving people. At Rocket, our Day of Service embodies this spirit by reinforcing Generosity as one of our core values, strengthening our bond as a team, and celebrating our company's founding by making a positive impact. Thank you to all the members of our team for their generosity and dedication to serving others. Whether participating in on-site activities, local projects, or individual volunteer efforts in the community, each member played a vital role in making this day a success. 🌍❤️🚀 #RocketPharma #DayOfService #RocketDayofService
Ähnliche Seiten
Jobs durchsuchen
Finanzierung
Letzte Runde
Eigenkapital nach dem IPOUS$ 175.0M